These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22500147)

  • 1. Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes.
    Profit L
    Core Evid; 2005; 1(2):89-101. PubMed ID: 22500147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled human insulin (Exubera): clinical profile and patient considerations.
    Barnett AH; Bellary S
    Vasc Health Risk Manag; 2007; 3(1):83-91. PubMed ID: 17583178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.
    Hollander PA
    MedGenMed; 2007 Mar; 9(1):45. PubMed ID: 17435648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.
    Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA
    Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial.
    Freemantle N; Strack TR;
    Trials; 2006 Aug; 7():25. PubMed ID: 16901335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.
    Black C; Cummins E; Royle P; Philip S; Waugh N
    Health Technol Assess; 2007 Sep; 11(33):1-126. PubMed ID: 17767897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled insulin: a clinical perspective with emphasis on EXUBERA
    Norwood P
    Expert Rev Endocrinol Metab; 2007 May; 2(3):313-320. PubMed ID: 30743801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.
    Alabraba V; Farnsworth A; Leigh R; Dodson P; Gough SC; Smyth T
    Diabetes Technol Ther; 2009 Jul; 11(7):427-30. PubMed ID: 19580355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus.
    Dunn C; Curran MP
    Treat Endocrinol; 2006; 5(5):329-31. PubMed ID: 17002493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled insulin: extending the horizons of inhalation therapy.
    Guntur VP; Dhand R
    Respir Care; 2007 Jul; 52(7):911-22. PubMed ID: 17594734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.
    Del Prato S; Blonde L; Martinez L; Göke B; Woo V; Millward A; Gomis R; Canovatchel B; Strack T; Lawrence D; Freemantle N;
    Diabet Med; 2008 Jun; 25(6):662-70. PubMed ID: 18435781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
    Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
    Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.
    Gerber RA; Cappelleri JC; Kourides IA; Gelfand RA
    Diabetes Care; 2001 Sep; 24(9):1556-9. PubMed ID: 11522698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.
    Dunn C; Curran MP
    Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.
    Hollander PA; Blonde L; Rowe R; Mehta AE; Milburn JL; Hershon KS; Chiasson JL; Levin SR
    Diabetes Care; 2004 Oct; 27(10):2356-62. PubMed ID: 15451900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.